Stock listing
Radiopharm Theranostics Limited
Selected listing: RADX · NASDAQ · USD · US
Radiopharm Theranostics Limited (NASDAQ:RADX), Health Services. Latest release Oct 5, 2026: Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S.…
- Ticker
- NASDAQ:RADX
- Asset type
- Stock
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- NASDAQ
- Currency
- USD
Latest news from Radiopharm Theranostics Limited
Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101
October 5, 2026
Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual Meeting
September 14, 2026
Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma
September 9, 2026
Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors
August 26, 2026
RAD Doses First Patient in Second Cohort of BetaBart (RV-01)
August 25, 2026
Research Radiopharm Theranostics Limited
Radiopharm Theranostics Limited company profile
View the public company page for Radiopharm Theranostics Limited on 6ix.
Radiopharm Theranostics Limited news
Read company news and market updates connected to Radiopharm Theranostics Limited.
Radiopharm Theranostics Limited investor events
Find investor webinars, events, and replay context for Radiopharm Theranostics Limited.
Alternate listings
RAD:ASX
AU · AUD
Alternate listing for Radiopharm Theranostics Limited; the primary context on this page is RADX:NASDAQ.
RDPTF:OTC
US · USD
Alternate listing for Radiopharm Theranostics Limited; the primary context on this page is RADX:NASDAQ.
RADX:BOATS
US · USD
Alternate listing for Radiopharm Theranostics Limited; the primary context on this page is RADX:NASDAQ.